SCHEMBL5144832

SCHEMBL5144832

CCn1cc(C(=O)O)c(=O)c2cc(F)c(Cl)nc21.F[B]F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.60
CYP2C9 P11712 1/20 0.60
ATP6V1B2 P21281 1/20 0.60
TBXA2R P21731 1/20 0.60
EDNRA P25101 1/20 0.60
TARBP2 Q15633 1/20 0.60
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
ABCC4 O15439 1/20 0.55
PKM P14618 1/20 0.55
PTGS1 P23219 1/20 0.55
TSHR P16473 3/20 0.49
HIF1A Q16665 1/20 0.49
CASP1 P29466 1/20 0.48
DRD3 P35462 1/20 0.47
HPGD P15428 7/20 0.46
HSD17B10 Q99714 7/20 0.46
KDM4E B2RXH2 7/20 0.46
ALDH1A1 P00352 6/20 0.46
BRD4 O60885 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6241091 0.96 LMNA (0.63) LMNACYP2C9ATP6V1B2TBXA2REDNRA
Fluoride SCHEMBL5144825 0.94 LMNA (0.61) LMNACYP2C9ATP6V1B2TBXA2REDNRA
SCHEMBL9288483 0.85 LMNA (0.51) LMNACYP2C9ATP6V1B2TBXA2REDNRA
SCHEMBL28331885 0.84 KDM4E (0.52) LMNACYP2C9ATP6V1B2TBXA2REDNRA
SCHEMBL11283163 0.84 LMNA (0.65) LMNACYP2C9ATP6V1B2TBXA2REDNRA
SCHEMBL16469689 0.83 LMNA (0.48) LMNACYP2C9ATP6V1B2TBXA2REDNRA
SCHEMBL3977245 0.83 ALDH1A1 (0.53) LMNACYP2C9ATP6V1B2TBXA2REDNRA
SCHEMBL10983165 0.82 LMNA (0.63) LMNACYP2C9ATP6V1B2TBXA2REDNRA
SCHEMBL14941582 0.81 LMNA (0.55) LMNACYP2C9ATP6V1B2TBXA2REDNRA
SCHEMBL6241096 0.81 LMNA (0.49) LMNACYP2C9ATP6V1B2TBXA2REDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7304050-B2 Antibacterial agents PFIZER INC. (US) 2007-12-04 US disclosed
US-20050070523-A1 Antibacterial agents HAGEN SUSAN (US) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070523-A1 Antibacterial agents MRPL21, ABCB11, NQO1 LMNA 3445/4885CYP2C9 488/4885ATP6V1B2 2231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.